153 related articles for article (PubMed ID: 15655527)
1. Voltage-dependent inhibition of recombinant NMDA receptor-mediated currents by 5-hydroxytryptamine.
Kloda A; Adams DJ
Br J Pharmacol; 2005 Feb; 144(3):323-30. PubMed ID: 15655527
[TBL] [Abstract][Full Text] [Related]
2. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors.
Kloda A; Clements JD; Lewis RJ; Adams DJ
Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832
[TBL] [Abstract][Full Text] [Related]
3. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
Williams K
Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
[TBL] [Abstract][Full Text] [Related]
4. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
Williams K
Mol Pharmacol; 1994 Sep; 46(3):531-41. PubMed ID: 7935335
[TBL] [Abstract][Full Text] [Related]
5. Influence of a threonine residue in the S2 ligand binding domain in determining agonist potency and deactivation rate of recombinant NR1a/NR2D NMDA receptors.
Chen PE; Johnston AR; Mok MH; Schoepfer R; Wyllie DJ
J Physiol; 2004 Jul; 558(Pt 1):45-58. PubMed ID: 15107472
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
Whittemore ER; Ilyin VI; Woodward RM
J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
[TBL] [Abstract][Full Text] [Related]
7. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
[TBL] [Abstract][Full Text] [Related]
8. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
[TBL] [Abstract][Full Text] [Related]
9. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subunits to inhibition by dynorphin.
Brauneis U; Oz M; Peoples RW; Weight FF; Zhang L
J Pharmacol Exp Ther; 1996 Dec; 279(3):1063-8. PubMed ID: 8968325
[TBL] [Abstract][Full Text] [Related]
11. NMDA receptor subunit-dependent modulation by conantokin-G and Ala7-conantokin-G.
Ragnarsson L; Yasuda T; Lewis RJ; Dodd PR; Adams DJ
J Neurochem; 2006 Jan; 96(1):283-91. PubMed ID: 16336218
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL.
Grauert M; Rho JM; Subramaniam S; Rogawski MA
J Pharmacol Exp Ther; 1998 May; 285(2):767-76. PubMed ID: 9580625
[TBL] [Abstract][Full Text] [Related]
13. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
[TBL] [Abstract][Full Text] [Related]
14. Subunit-specific effects of poricoic acid A on NMDA receptors.
Lee J; Kim C; Yeom HD; Nguyen KVA; Eom S; Lee S; Jung JH; Lee JH; Kim SH; Kim IK; Lee JH
Pharmacol Rep; 2020 Apr; 72(2):472-480. PubMed ID: 32048268
[TBL] [Abstract][Full Text] [Related]
15. Mutations within the selectivity filter of the NMDA receptor-channel influence voltage dependent block by 5-hydroxytryptamine.
Kloda A; Adams DJ
Br J Pharmacol; 2006 Sep; 149(2):163-9. PubMed ID: 16894346
[TBL] [Abstract][Full Text] [Related]
16. Effects of extracellular pH on the dynorphin A inhibition of N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Oz M; Woods AS; Shippenberg T; Kaminski RM
Synapse; 2004 May; 52(2):84-8. PubMed ID: 15034914
[TBL] [Abstract][Full Text] [Related]
17. Voltage-dependent block of NMDA responses by 5-HT agonists in ventral spinal cord neurones.
Chesnoy-Marchais D; Barthe JY
Br J Pharmacol; 1996 Jan; 117(1):133-41. PubMed ID: 8825354
[TBL] [Abstract][Full Text] [Related]
18. Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors.
Kurkó D; Dezso P; Boros A; Kolok S; Fodor L; Nagy J; Szombathelyi Z
Neurochem Int; 2005 Apr; 46(5):369-79. PubMed ID: 15737435
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
Kiss L; Cheng G; Bednar B; Bednar RA; Bennett PB; Kane SA; McIntyre CJ; McCauley JA; Koblan KS
Neurochem Int; 2005 May; 46(6):453-64. PubMed ID: 15769547
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
